NovaNex offers two established reproductive pathways, with a third row approaching public release.
An established transformation pathway designed for clients seeking anatomical expansion while preserving their existing reproductive function.
An advanced transformation pathway designed for clients seeking spermogenic reproductive function through guided gonadal conversion.
A forthcoming NovaNex pathway currently undergoing final readiness review. Public details will be released as milestones are reached.
| CAN BECOME PREGNANT BY | |||||
|---|---|---|---|---|---|
| Women | Series 1 | Series 2 | Series 3 | ||
| CAN INITIATE PREGNANCY | Men | TBA | |||
| Series 1 | TBA | ||||
| Series 2 | TBA | ||||
| Series 3 | TBA | TBA | TBA | TBA | |
Compatibility assumes ordinary fertility and does not replace individual clinical guidance.
Series 1 is an ovarian-preserving pathway, while Series 2 adds guided spermogenic conversion. Both include integrated phallic and scrotal anatomy, but they differ in reproductive focus and endocrine monitoring intensity.
Yes. Both established pathways are designed to retain uterine gestational capacity for clinically eligible clients after recovery and clearance.
Both pathways include integrated phallic and scrotal structures. Series 2 additionally introduces gonadal conversion protocols that support spermogenic function under structured monitoring.
In many cases, yes. NovaNex can evaluate Series 1 clients for staged conversion eligibility based on healing history, endocrine profile, fertility goals, and anatomical readiness.
Every consultation includes pathway counseling, reproductive planning, risk review, and recovery expectations so clients can choose a route aligned with their goals and comfort level.
Series 3 details will be published once final readiness milestones are completed. Public updates are released through NovaNex newsroom and official consultation channels.